Evotec SE - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
EVO Nasdaq 2830 www.evotec.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Evotec SE

Evotec Receives Grant from Korean Government to Develop Novel Antibody-based Treatments for Lung Diseases - Jan 22nd, 2025 7:00 am
Evotec SE announces first projects for LAB eN(2) drug discovery accelerator with Novo Nordisk - Dec 11th, 2024 7:00 am
Sector Update: Health Care Stocks Rise in Afternoon Trading - Nov 29th, 2024 5:49 pm
Evotec Announces Change in Management Board - Nov 29th, 2024 7:00 am
HALO Withdraws Acquisition Bid for EVO, Reaffirms '24 View, Stock Up - Nov 25th, 2024 3:40 pm
Halozyme Withdraws Evotec Bid After Rebuff, Reaffirms Strong Growth Outlook - Nov 22nd, 2024 5:12 pm
Comment on Withdrawn Non-Binding Offer - Nov 22nd, 2024 4:15 pm
Halozyme shares jump 12% as it scraps $2.1 bln Evotec deal - Nov 22nd, 2024 2:21 pm
Halozyme withdraws $2.1 billion buyout offer for German drug developer Evotec - Nov 22nd, 2024 1:55 pm
Halozyme Withdraws Proposal to Acquire Evotec Following Evotec's Unwillingness to Engage in Discussions - Nov 22nd, 2024 1:35 pm
Halozyme drops Evotec buyout bid; Patient dies in Neurogene trial - Nov 22nd, 2024 10:30 am
Is Evotec SE (EVO) the Best German Stock to Buy Now? - Nov 19th, 2024 11:01 pm
Halozyme Provides Update on Non-Binding Proposal to Combine with Evotec - Nov 18th, 2024 12:00 pm
Large Pharma Partner Halozyme Therapeutics Offers To Acquire Germany-Based Evotec For ~$2 Billion - Nov 15th, 2024 5:56 pm
Halozyme Submits $2.11 Billion Acquisition Offer For Evotec - Nov 15th, 2024 11:31 am
Evotec shares surge 20% on Halozyme's 2 billion euro takeover bid - Nov 15th, 2024 10:11 am
Halozyme bids for Evotec; BeiGene gets a new name - Nov 15th, 2024 10:00 am
Halozyme Confirms Proposal to Combine with Evotec for €11.00 Per Share in an All-Cash Transaction - Nov 14th, 2024 9:15 pm
Evotec Third Quarter 2024 Earnings: Misses Expectations - Nov 12th, 2024 6:13 am
Private Equity Triton Partners Takes Around 10% Stake In Evotec, Reportedly Mulls Potential Takeover Deal - Nov 11th, 2024 3:52 pm